Pentavere Research Group Inc. has been awarded the first Takeda Canada Innovation Challenge. The Innovation Challenge was launched in January 2022 to accelerate partnerships in identifying new digital technologies and artificial intelligence (AI) solutions that support enhanced patient care in inflammatory bowel disease (IBD) or rare disease conditions.
Pentavere Research Group Inc. is a clinical discovery company that has developed a breakthrough, proprietary, artificial intelligence (AI) engine called DARWEN™, which accelerates discovery from vast amounts of clinical text. DARWEN™ unlocks value, insights and evidence from clinical information which is impossible to analyze by human intelligence alone.
Pentavere will have the opportunity to collaborate and benefit from Takeda’s expertise and extensive international network, as well as funding, to build a proof of concept project in the areas of rare diseases.
The Takeda Canada Innovation Challenge received multiple submissions within the fields of early diagnosis or integrated and personalized care, applicable to the therapeutic areas of inflammatory bowel disease (ulcerative colitis or Crohn’s disease) or rare genetic diseases.
Patient-led Innovations in Inflammatory Bowel Disease Take the Prize in Takeda Canada’s Digital Health Challenge
Posted in Commentary with tags Takeda on September 20, 2023 by itnerdTakeda Canada Inc. has announced two winners of the 2023 Takeda Canada Digital Health Innovation Challenge, a competition to identify and support innovative digital health solutions to improve patient outcomes and experiences.
This year’s challenge winners are two patient-led organizations with disruptive digital solutions aimed at improving the patient journey in Inflammatory Bowel Disease (IBD), the most common forms being Ulcerative Colitis and Crohn’s Disease. The two companies are IBDrelief and Ayble Health.
Ayble Health is an all-in-one virtual gastroenterology platform that helps digestive disease patients, including those with inflammatory bowel disease, find long-term relief and control over their symptoms. Ayble developed the largest GI behavioral health database in the world to build a personalized nutrition and behavioral health program for every patient, supported by a licensed coaching team. Ayble’s best-in-class outcomes are backed by 14 peer-reviewed studies developed in partnership with Northwestern University, Harvard Medical School, Mayo Clinic and Cleveland Clinic.
IBDrelief is a social enterprise that provides vital support and information to people living with IBD, their families, and the medical industry to help improve people’s quality of life. Their education platform IBDmate, allows healthcare teams to ‘prescribe’ educational videos to patients and their families prior to and after appointments. Developed in conjunction with the Cambridge University Hospital (CUH) paediatric IBD team at Addenbrooke’s Hospital, IBDmate has shown a positive impact on patients and the hospital’s IBD service through increased knowledge, accessibility, medication adherence, and trust in information.
The winners of the challenge will receive a $10,000 CAD cash prize and the opportunity to participate in Plug and Play Alberta’s Fall 2023 Accelerator Program, with the potential to further explore funding from Takeda Canada to build a proof-of-concept project. For more details and full challenge terms and conditions visit: https://takeda.info/ca-innovationchallenge.
Leave a comment »